Real earnings management, poison pill and IPO failure
| Model 1 | Model 2 | Model 3 | Model 4 | |
|---|---|---|---|---|
| AbnCFO | 0.098 | |||
| (1.534) | ||||
| AbnProd | 0.758** | |||
| (2.435) | ||||
| AbnDISX | 0.109*** | |||
| (4.818) | ||||
| Rm_PROXY | 0.129*** | |||
| (4.032) | ||||
| Abs_DA | 0.066 | −0.686 | −0.831 | −1.067 |
| (0.088) | (−0.890) | (−1.149) | (−1.337) | |
| Poison Pill | 0.526*** | 0.516*** | 0.507*** | 0.534*** |
| (5.019) | (4.874) | (4.816) | (5.070) | |
| Offerprice | −0.003 | −0.003 | −0.003 | −0.003 |
| (−1.579) | (−1.364) | (−1.204) | (−1.320) | |
| Firstday_ret | 0.003 | 0.003 | 0.003 | 0.003 |
| (0.937) | (0.854) | (0.878) | (0.879) | |
| BTM | 0.347** | 0.289* | 0.349** | 0.299** |
| (2.369) | (1.916) | (2.326) | (1.998) | |
| Leverage | −0.220 | 0.325** | −0.277 | −0.257* |
| (−1.554) | (2.256) | (−1.906) | (−1.786) | |
| Logage | −0.001 | 0.005 | 0.018 | 0.027 |
| (−0.018) | (0.075) | (0.262) | (0.392) | |
| ROA | −0.753 | −3.063*** | −2.674*** | −2.870*** |
| (−1.368) | (−5.099) | (−4.543) | (−4.839) | |
| Overhang | −0.000 | −0.000 | −0.000 | −0.000 |
| (−0.814) | (−0.775) | (−0.729) | (−0.727) | |
| VC_Dummy | 0.154 | 0.100 | 0.066 | 0.108 |
| (1.350) | (0.862) | (0.570) | (0.933) | |
| Big4 | −0.036 | −0.015 | −0.033 | −0.048 |
| (−0.342) | (−0.139) | (−0.311) | (−0.452) | |
| Gross_margin | −0.189 | −0.349** | −0.369** | −0.205 |
| (−1.189) | (−1.992) | (−2.097) | (−1.301) | |
| Nidummy | 0.089 | −0.157 | −0.182 | −0.150 |
| (0.592) | (−0.974) | (−1.132) | (−0.939) | |
| Constant | 1.887 | 2.263 | 2.597 | 2.076 |
| (1.241) | (1.425) | (1.637) | (1.313) | |
| Firm and year fixed effects | Yes | Yes | Yes | Yes |
| Wald χ2 | 332.49 | 357.42 | 365.60 | 354.89 |
| Log pseudolikelihood | −1467.31 | −1458.30 | −1449.76 | −1453.26 |
| Observations | 2,997 | 2,997 | 2,997 | 2,997 |
| Pseudo R2 | 0.129 | 0.134 | 0.139 | 0.137 |
| Model 1 | Model 2 | Model 3 | Model 4 | |
|---|---|---|---|---|
| AbnCFO | 0.098 | |||
| (1.534) | ||||
| AbnProd | 0.758** | |||
| (2.435) | ||||
| AbnDISX | 0.109*** | |||
| (4.818) | ||||
| Rm_PROXY | 0.129*** | |||
| (4.032) | ||||
| Abs_DA | 0.066 | −0.686 | −0.831 | −1.067 |
| (0.088) | (−0.890) | (−1.149) | (−1.337) | |
| Poison Pill | 0.534*** | |||
| (5.070) | ||||
| Offerprice | −0.003 | −0.003 | −0.003 | −0.003 |
| (−1.579) | (−1.364) | (−1.204) | (−1.320) | |
| Firstday_ret | 0.003 | 0.003 | 0.003 | 0.003 |
| (0.937) | (0.854) | (0.878) | (0.879) | |
| BTM | 0.347** | 0.289* | 0.349** | 0.299** |
| (2.369) | (1.916) | (2.326) | (1.998) | |
| Leverage | −0.220 | 0.325** | −0.277 | −0.257* |
| (−1.554) | (2.256) | (−1.906) | (−1.786) | |
| Logage | −0.001 | 0.005 | 0.018 | 0.027 |
| (−0.018) | (0.075) | (0.262) | (0.392) | |
| ROA | −0.753 | −3.063*** | −2.674*** | −2.870*** |
| (−1.368) | (−5.099) | (−4.543) | (−4.839) | |
| Overhang | −0.000 | −0.000 | −0.000 | −0.000 |
| (−0.814) | (−0.775) | (−0.729) | (−0.727) | |
| VC_Dummy | 0.154 | 0.100 | 0.066 | 0.108 |
| (1.350) | (0.862) | (0.570) | (0.933) | |
| Big4 | −0.036 | −0.015 | −0.033 | −0.048 |
| (−0.342) | (−0.139) | (−0.311) | (−0.452) | |
| Gross_margin | −0.189 | −0.349** | −0.369** | −0.205 |
| (−1.189) | (−1.992) | (−2.097) | (−1.301) | |
| Nidummy | 0.089 | −0.157 | −0.182 | −0.150 |
| (0.592) | (−0.974) | (−1.132) | (−0.939) | |
| Constant | 1.887 | 2.263 | 2.597 | 2.076 |
| (1.241) | (1.425) | (1.637) | (1.313) | |
| Firm and year fixed effects | Yes | Yes | Yes | Yes |
| Wald | 332.49 | 357.42 | 365.60 | 354.89 |
| Log pseudolikelihood | −1467.31 | −1458.30 | −1449.76 | −1453.26 |
| Observations | 2,997 | 2,997 | 2,997 | 2,997 |
| Pseudo R2 | 0.129 | 0.134 | 0.139 | 0.137 |
Note(s): This table reports results from regressing IPO real earnings management on IPO failure while controlling for poison pill from 1993 to 2015. Our dependent variable is a dummy variable equal to 1 if the firm failed within five years. Models 1 to 3 report the logistic regression results of from regressing AbnCFO, AbnPROD and AbnDISX on IPO failure controlling for poison pill. Model 4 presents the results from regressing the aggregate measure of real earnings management. Appendix outlines definitions and data sources for the regression variables. Robust t-statistics adjusted for clustering by firm are reported inside the parentheses
* Statistical significance at the 10% level
** Statistical significance at the 5% level
*** Statistical significance at the 1% level
Source(s): Table by authors
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.